138 related articles for article (PubMed ID: 16837817)
1. Erythropoietin in experimental acute renal failure.
Sharples EJ; Yaqoob MM
Nephron Exp Nephrol; 2006; 104(3):e83-8. PubMed ID: 16837817
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model.
Spandou E; Tsouchnikas I; Karkavelas G; Dounousi E; Simeonidou C; Guiba-Tziampiri O; Tsakiris D
Nephrol Dial Transplant; 2006 Feb; 21(2):330-6. PubMed ID: 16221709
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin attenuates renal and pulmonary injury in polymicrobial induced-sepsis through EPO-R, VEGF and VEGF-R2 modulation.
Heitrich M; García DM; Stoyanoff TR; Rodríguez JP; Todaro JS; Aguirre MV
Biomed Pharmacother; 2016 Aug; 82():606-13. PubMed ID: 27470403
[TBL] [Abstract][Full Text] [Related]
4. The administration of erythropoietin attenuates kidney injury induced by ischemia/reperfusion with increased activation of Wnt/β-catenin signaling.
Chen X; Wang CC; Song SM; Wei SY; Li JS; Zhao SL; Li B
J Formos Med Assoc; 2015 May; 114(5):430-7. PubMed ID: 25682558
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin and acute renal failure.
Sharples EJ; Yaqoob MM
Semin Nephrol; 2006 Jul; 26(4):325-31. PubMed ID: 16949472
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin protects the kidneys against ischemia reperfusion injury by activating hypoxia inducible factor-1alpha.
Imamura R; Moriyama T; Isaka Y; Namba Y; Ichimaru N; Takahara S; Okuyama A
Transplantation; 2007 May; 83(10):1371-9. PubMed ID: 17519789
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin protects against ischaemic acute renal injury.
Vesey DA; Cheung C; Pat B; Endre Z; Gobé G; Johnson DW
Nephrol Dial Transplant; 2004 Feb; 19(2):348-55. PubMed ID: 14736958
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin attenuates apoptosis after ischemia-reperfusion-induced renal injury in transiently hyperglycemic Wister rats.
Caetano AM; Vianna Filho PT; Castiglia YM; Golim MA; de Souza AV; de Carvalho LR; Deffune E; de Oliveira C; Vianna PT
Transplant Proc; 2011 Dec; 43(10):3618-21. PubMed ID: 22172815
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of lipopolysaccharide-induced acute kidney injury by erythropoietin: involvement of mitochondria-regulated apoptosis.
Stoyanoff TR; Todaro JS; Aguirre MV; Zimmermann MC; Brandan NC
Toxicology; 2014 Apr; 318():13-21. PubMed ID: 24561306
[TBL] [Abstract][Full Text] [Related]
10. Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure.
Johnson DW; Pat B; Vesey DA; Guan Z; Endre Z; Gobe GC
Kidney Int; 2006 May; 69(10):1806-13. PubMed ID: 16598197
[TBL] [Abstract][Full Text] [Related]
11. Effect of erythropoietin on mesenchymal stem cell differentiation and secretion in vitro in an acute kidney injury microenvironment.
Liu NM; Tian J; Wang WW; Han GF; Cheng J; Huang J; Zhang JY
Genet Mol Res; 2013 Feb; 12(4):6477-87. PubMed ID: 23479159
[TBL] [Abstract][Full Text] [Related]
12. Increased progression to kidney fibrosis after erythropoietin is used as a treatment for acute kidney injury.
Gobe GC; Bennett NC; West M; Colditz P; Brown L; Vesey DA; Johnson DW
Am J Physiol Renal Physiol; 2014 Mar; 306(6):F681-92. PubMed ID: 24402097
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin-mediated protection in kidney transplantation: nonerythropoietic EPO derivatives improve function without increasing risk of cardiovascular events.
van Rijt WG; van Goor H; Ploeg RJ; Leuvenink HG
Transpl Int; 2014 Mar; 27(3):241-8. PubMed ID: 23964738
[TBL] [Abstract][Full Text] [Related]
14. Recombinant erythropoietin rapidly treats anemia in ischemic acute renal failure.
Nemoto T; Yokota N; Keane WF; Rabb H
Kidney Int; 2001 Jan; 59(1):246-51. PubMed ID: 11135077
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin pretreatment ameliorates renal ischaemia-reperfusion injury by activating PI3K/Akt signalling.
Zhang J; Zou YR; Zhong X; Deng HD; Pu L; Peng K; Wang L
Nephrology (Carlton); 2015 Apr; 20(4):266-72. PubMed ID: 25581532
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin ameliorates renal ischemia and reperfusion injury via inhibiting tubulointerstitial inflammation.
Hu L; Yang C; Zhao T; Xu M; Tang Q; Yang B; Rong R; Zhu T
J Surg Res; 2012 Jul; 176(1):260-6. PubMed ID: 21816412
[TBL] [Abstract][Full Text] [Related]
17. Post-treatment effects of erythropoietin and nordihydroguaiaretic acid on recovery from cisplatin-induced acute renal failure in the rat.
Lee DW; Kwak IS; Lee SB; Song SH; Seong EY; Yang BY; Lee MY; Sol MY
J Korean Med Sci; 2009 Jan; 24 Suppl(Suppl 1):S170-5. PubMed ID: 19194548
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin administration is associated with short-term improvement in glomerular filtration rate after ischemia-reperfusion injury.
Sølling C; Christensen AT; Krag S; Frøkiaer J; Wogensen L; Krog J; Tønnesen EK
Acta Anaesthesiol Scand; 2011 Feb; 55(2):185-95. PubMed ID: 21226860
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion.
Sharples EJ; Patel N; Brown P; Stewart K; Mota-Philipe H; Sheaff M; Kieswich J; Allen D; Harwood S; Raftery M; Thiemermann C; Yaqoob MM
J Am Soc Nephrol; 2004 Aug; 15(8):2115-24. PubMed ID: 15284297
[TBL] [Abstract][Full Text] [Related]
20. EPO and alpha-MSH prevent ischemia/reperfusion-induced down-regulation of AQPs and sodium transporters in rat kidney.
Gong H; Wang W; Kwon TH; Jonassen T; Li C; Ring T; FrøkiAEr J; Nielsen S
Kidney Int; 2004 Aug; 66(2):683-95. PubMed ID: 15253723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
